CSF3
protein-codingcolony stimulating factor 3, the group of Receptor ligands
Gene summary
This gene encodes a member of the IL-6 superfamily of cytokines. The encoded cytokine controls the production, differentiation, and function of granulocytes. Granulocytes are a type of white blood cell that are part of the innate immune response. A modified form of this protein is commonly administered to manage chemotherapy-induced neutropenia. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2020]
- GCSF
- G-CSF
- C17orf33
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~2.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014865
Submitter: LiferaOmics
Genetic evidence – Published: PMID: 37612131 reports 3 affected individuals from 2 consanguineous families with biallelic inactivating CSF3 variants. Family 1 includes 1 proband and 1 affected homozygous sibling (sibling counted as segregation, not independent proband); Family 2 includes 1 proband. Case-level (biallelic predicted null in AR model; homozygous scored once; consanguinity deduction applied) = 1.0 per family proband = 2.0; segregation (affected homozygous sibling in Family 1) = 0.5; case-control = 0. Published genetic evidence total = 2.5/12 Genetic evidence – our case: homozygous nonsense NM_000759.4:c.457C>T;p.(Gln153*) in a consanguineous family (predicted loss-of-function). Case-level (biallelic predicted null in AR model; homozygous scored once; consanguinity deduction applied) = 1.0; segregation = 0; case-control = 0. Current case contribution = 1.0/12 Total genetic evidence (published + our case) = 3.5/12 Experimental evidence – Published: CSF3 encodes G-CSF regulating neutrophil production (biochemical function) = 0.5. PMID: 37612131 demonstrates nonsense-mediated decay in patient-derived RNA (functional alteration in patient cells) = 1.0. Csf3 knockout mouse model shows chronic neutropenia (non-human model organism) = 2.0 Experimental evidence total = 3.5/6 Overall score = 7.0
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CSF3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_172219.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 3 | 4 | |||
| missense | 21 | 2 | 23 | |||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 2 | 0 | 22 | 0 | 5 | 29 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_757373.1 | 5 | MANE Select | |
| Ensembl | ENSP00000377705.4 | 5 | MANE Select | |
| RefSeq | NP_000750.1 | 5 | Standard | |
| RefSeq | NP_001171618.1 | 4 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| csf3b | Danio rerio | Structure: blood island Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- PI3K-Akt signaling pathway - Homo sapiens (human)
- Jak-STAT signaling pathway - Homo sapiens (human)
- Malaria - Homo sapiens (human)
- IL-17 signaling pathway - Homo sapiens (human)
- Hematopoietic cell lineage - Homo sapiens (human)
Biological Process
- immune response
- multicellular organism development
- positive regulation of cell population proliferation
- regulation of signaling receptor activity
- positive regulation of phosphatidylinositol 3-kinase signaling
Molecular Function
- cytokine activity
- granulocyte colony-stimulating factor receptor binding
- growth factor activity
- enzyme binding
Cellular Component
- extracellular region
- extracellular space
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000225474
- Coding exons
- 5
- Length
- 2453
- Individuals with no LoFs
- 125696
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125700
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.976 | 87 | 117 | 0.746 | 0.00000667 | 1311 |
| Missense (PolyPhen) | 25 | 39.228 | 0.6373 | 488 | ||
| Synonymous | -0.0144 | 55 | 54.9 | 1.00 | 0.00000351 | 439 |
| Loss of Function | 2.18 | 2 | 9.11 | 0.220 | 3.91e-7 | 99 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Granulocyte/macrophage colony-stimulating factors are cytokines that act in hematopoiesis by controlling the production, differentiation, and function of 2 related white cell populations of the blood, the granulocytes and the monocytes-macrophages. This CSF induces granulocytes.;
Recessive Scores
- pRec
- 0.850
Intolerance Scores
- LoFtool
- 0.643
- RVIS EVS
- 0.22
- RVIS percentile EVS
- 68.13
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.817
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |